UK-based medical technology company Smith+Nephew has introduced the TRIGEN MAX Tibia Nailing System, designed for stable and unstable tibial fractures, including the shaft.
The system provides trauma surgeons with side-specific nails for anatomic screw trajectories, enhancing fragment fixation.
Also, it helps reduce soft tissue irritation with headless and low-profile screw options to optimise surgical outcomes and streamline procedures.
The TRIGEN MAX Tibia Nailing System features a surgeon-centred design with components and instrumentation aimed at increasing efficiency.
Its key elements include a two-piece modular drop system to support ancillary instruments and visualisation, and a 12.5mm channel reamer to preserve entry point integrity.
The system also includes 5.0mm Lag Screws that compress fractures in a single insertion step, facilitating a streamlined workflow.
Smith+Nephew trauma and extremities marketing vice president Mark McMahan said: “The first case using the TRIGEN MAX Tibia Nailing System was completed last week, representing a significant advancement in lower extremity trauma care.
“By focusing on both implant innovation and instrumentation, we’re delivering a smarter, more adaptable solution for today’s orthopaedic challenges.”
Smith+Nephew’s TRIGEN Nails are renowned for performance and design for over two decades.
The company launched the new TRIGEN MAX Tibia Nailing System as its lead product, setting a new standard of care for intramedullary nails.
Atrium Health orthopaedic trauma surgeon Joseph Hsu said: “What takes the TRIGEN MAX Tibia Nailing System to the next level is its ability to reach fractures we never imagined treating with an intramedullary implant before – but we’re there now.
“It’s not just a nail, it’s a platform that allows us to rethink how we approach complex injuries. Most importantly, it makes those treatments reproducible.
“What’s especially exciting is that the TRIGEN MAX system represents a truly patient-centred approach; from the design of the instruments to the implants themselves, it’s all about optimising recovery and addressing each patient’s unique anatomy and potential complications.”
Earlier in the year, Smith+Nephew launched a foot and ankle repair portfolio in Australia and New Zealand, to help surgeons refine suture tension post-anchor insertion.
The foot and ankle portfolio includes the ULTRABRIDGE Adjustable Achilles Reconstruction and ULTRABRACE Adjustable Ankle Instability Techniques.
It also features an all-suture anchor with consistent deployment and strong fixation, now integrated with needles for open procedures.
